Endothelial control of lower limb blood flow in chronic heart failure

Heart

Volumn 75, Issue 5, 1996, Pages 469-476

  Lindsay, David C ^a,c   Holdright, Diana R ^a   Clarke, Debbie ^a   Anand, Inder S ^b   Poole Wilson, Philip A ^a   Collins, Peter ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Congestive heart failure; Endothelium derived relaxing factor; Vasodilatation

Indexed keywords

ACETYLCHOLINE; NITRIC OXIDE; PAPAVERINE; SUBSTANCE P;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM; FEMALE; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEG BLOOD FLOW; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE; VASODILATATION;

EID: 0029936969     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.5.469     Document Type: Article

References (53)

1. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989;80:769-81.
2. Roleau J, Kortas C, Eichet D, de Champlain J. Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms. Am Heart J 1988;116:746-57.
3. Fink LI, Wilson JR, Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 1986;57:249-53.
4. Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24:437-59.
5. Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-70.
6. LeJemtel TH, Maskin CS, Lucido D, Chadwick BJ. Failure to augment maximal limb blood flow in response to one- leg versus two-leg exercise in patients with severe heart failure. Circulation 1986;74:245-51.
7. Lipkin DP, Jones DA, Round JM, Poole-Wilson PA. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988;18:187-95.
8. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long- term heart failure. Circulation 1990;81:518-27.
9. Mancini DM, Coyle E, Coggan A, et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989;80:1338-46.
10. Piepoli M, Clark AL, Volterrani M, et al. Muscle ergoreflex role in exertional dyspnea in chronic heart failure patients [abstract]. J Am Coll Cardiol 1993;21:480A.
11. Collier J, Vallance P. Endothelium-derived relaxing factor is an endogenous vasodilator in man. Br J Pharmacol 1989;97:639-41.
12. Ontkean M, Gay R, Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 1991;69: 1088-96.
13. Lindsay DC, Jiang C, Brunotte F, et al. Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res 1992;26:694-7.
14. Drexler H, Hablawetz E, Lu W, Riede U, Christes A. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation 1992;86:255-62.
15. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25.
16. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96.
17. Drexler H, Hayoz D, Münzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992; 69:1596-601.
18. Arnold JMO, Marchiori GE, Imrie JR, Burton GL, Pflugfelder PW, Kostuk WJ. Large artery function in patients with chronic heart failure. Studies of brachial artery diameter and hemodynamics. Circulation 1991; 84:2418-25.
19. Sinoway LI, Minotti JR, Davis D, et al. Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation. Am J Cardiol 1988;61:1076-9.
20. Bassenge E, Munzel T. Consideration of conduit and resistance vessels in regulation of blood flow. Am J Cardiol 1988;62:40-4E.
21. Leier CV, Binkley PF, Cody RJ. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure. Circulation 1990;82:168-76.
22. Griffith TM, Edwards DH, Davies RL, Henderson AH. The role of EDRF in flow distribution: a microangiographic study of the rabbit isolated ear. Microvasc Res 1989;37:162-77.
23. Vallance P, Collier J, Moncada S. Effects of endothelium- derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
24. Leier CV. Regional blood flow responses to vasodilators and inotropes in congestive heart failure. Am J Cardiol 1988;62:86-93E.
25. Zijlstra F, Serruys PW, Hugenholtz PG. Papaverine: the ideal coronary vasodilator for investigating coronary flow- reserve? A study of timing, magnitude, reproducibility, and safety of the coronary hyperaemic response to intracoronary papaverine. Cathet Cardiovasc Diagn 1986;12: 298-303.
26. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 1989;79:1043-51.
27. Deighton NM, Zerkowski H, Brodde OE. Muscarinic receptor number and functional responsiveness in patients with mild-to-moderate or end-stage heart failure [abstract]. Eur Heart J 1990;11:71.
28. Vatner DE, Lee DL, Schwarz KR, et al. Impaired cardiac muscarinic receptor function in dogs with heart failure. J Clin Invest 1988;81:1836-42.
29. Crossman DC, Larkin SW, Fuller RW, Davies GJ, Maseri A. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation 1989;80:475-84.
30. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
31. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
32. Werns SW, Walton JA, Hsia HH, Nabal EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989;79:287-91.
33. Sax FL, Cannon RO, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina. N Engl J Med 1987;317:1366-70.
34. Linder L, Kiowski W, Bühler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990;81:1762-7.
35. Luscher TF, Yang Z, Diederich D, Bühler FR. Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion. J Cardiovasc Pharmacol 1989;14(suppl 6):S63-9.
36. Wright CE, Angus JA. Effects of hypertension and hypercholesterolemia on vasodilatation in the rabbit. Hypertension 1986;8:361-71.
37. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-34.
38. Mayhan WG. Impairment of endothelium-dependent dilation of arterioles during diabetes mellitus. Am J Physiol 1989;256:H621-5.
39. Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 1989;79:491-502.
40. Hirooka Y, Imaizumi T, Takeshita A, Ando S, Haroda S. Impaired endothelial-dependent forearm vasodilation to acetylcholine in patients with essential hypertension and effects of captopril [abstract]. Circulation 1990;82(suppl III):III-346.
41. Vanhoutte PM. Endothelial-derived relaxing and contracting factors. Heart Failure 1989;5:5-12.
42. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992;20:1549-55.
43. Wilson JR, Martin JL, Ferraro N, Weber KT. Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure. Circulation 1983;68:425-32.
44. Jorfeldt L, Wahren J. Leg blood flow during exercise in man. Clin Sci 1971;41:459-73.
45. Wilson JR, Ferraro N, Wiener DH. Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in patients with heart failure. Circulation 1985;72:72-81.
46. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986;250:H1145-9.
47. Zelis R, Mason DT. Diminished forearm arteriolar dilator capacity produced by mineralocorticoid-induced salt retention in man. Implications concerning congestive heart failure and vascular stiffness. Circulation 1970;41: 589-92.
48. Zelis R, Delea CS, Coleman HN, Mason DT. Arterial sodium content in experimental congestive heart failure. Circulation 1970;41:213-6.
49. Zelis R, Lee G, Mason DT. Influence of experimental edema on metabolically determined blood flow. Circ Res 1974;34:482-90.
50. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-9.
51. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323: 236-41.
52. Kaiser L, Spickard RC, Olivier NB. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962-7.
53. Dzau VJ, Swartz SL. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1987;60:1101-5.